JPRN-UMIN000043068招募中未知
Effect of insulin glargine and lixisenatide and insulin degludec and liraglutide on glucose variability and oxidative stress in type 2 diabetes patients - Effect of insulin glargine and lixisenatide and insulin degludec and liraglutide on glucose variability and oxidative stress in type 2 diabetes patients
Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine0 个研究点目标入组 30 人开始时间: 2021年1月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)the use of steroids or anti-inflammatory drugs, 2)diabetic ketosis and coma within 3 months before the study, 3)severe infection, severe trauma, pre-and post-operation, 4)an estimated glomerular filtration rate are within 30mL/min/1.73m2, 5)malignancy, 6)pregnancy 7)Patients who are judged as inappropriate for inclusion by phsicians
研究者
相似试验
进行中（未招募）
1 期
Effect of insulin glargine and lixisenatide versus insulin glargine on brain insulin sensitivity in patients with type 2 diabetesEUCTR2018-003557-21-DEniversity Hospital Tuebingen40
已完成
2 期
Insulin glargine and acarbose in the treatment of type II diabetesDiabet mellitus.non insulin dependent diabetes mellitusIRCT201403041774N6Physiology research center, Vice chancellor for Research and Technology of kerman medical University152
进行中（未招募）
不适用
Effect of insulin glulisine compared to insulin aspart and insulin lispro when administered by Continuous Subcutaneous Insulin Infusion (CSII) on specific pump parameters in patient with Type 1 Diabetes Mellitus - Pump StudyType I Diabetes MellitusMedDRA version: 9.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusEUCTR2007-003579-38-ATsanofi-aventis groupe270
进行中（未招募）
不适用
Effect of insulin glulisine compared to insulin aspart and insulin lispro when administered by Continuous Subcutaneous Insulin Infusion (CSII) on specific pump parameters in patient with Type 1 Diabetes Mellitus - Pump StudyType I Diabetes MellitusMedDRA version: 9.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusEUCTR2007-003579-38-NLsanofi-aventis groupe270
进行中（未招募）
不适用
Effect of insulin glulisine compared to insulin aspart and insulin lispro when administered by Continuous Subcutaneous Insulin Infusion (CSII) on specific pump parameters in patient with Type 1 Diabetes Mellitus - Pump StudyType I Diabetes MellitusMedDRA version: 9.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusEUCTR2007-003579-38-GBsanofi-aventis groupe270